CoChat

Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is defined by the degeneration of nigral dopaminergic (DA) neurons and can be caused by monogenic mutations of genes such as parkin. The lack of phenotype in parkin knockout mice suggests that human nigral DA neurons have unique vulnerabilities. Here we generate induced pluripotent stem cells from normal subjects and PD patients with parkin mutations. We demonstrate that loss of parkin in human midbrain DA neurons greatly increases the transcription of monoamine oxidases and oxidative stress, significantly reduces DA uptake and increases spontaneous DA release. Lentiviral expression of parkin, but not its PD-linked mutant, rescues these phenotypes. The results suggest that parkin controls dopamine utilization in human midbrain DA neurons by enhancing the precision of DA neurotransmission and suppressing dopamine oxidation. Thus, the study provides novel targets and a physiologically relevant screening platform for disease-modifying therapies of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms1669

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. Chambers SM Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat Biotechnol 27 275 280 2009 19252484 PMC2756723

Cited by

Metadata

Authors
Jiang, H., Ren, Y., Yuen, E. Y., Zhong, P., Ghaedi, M., Hu, Z., Azabdaftari, G., Nakaso, K., Yan, Z., & Feng, J.
Affiliations
  • University at Buffalo, State University of New York (US)
  • Roswell Park Comprehensive Cancer Center (US)
  • Tottori University (JP)
Corresponding author
Feng, Jian
Venue
Nature Communications
Published
2012-02-07
Volume
3
Issue
1
Pages
668-668
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2010478595
Cited by
254
References
39
Citations by year
2026: 5 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 19 · 2021: 20 · 2020: 16 · 2019: 26 · 2018: 24 · 2017: 16 · 2016: 24 · 2015: 17 · 2014: 18 · 2013: 24 · 2012: 15
FWCI
15.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Michael J. Fox Foundation for Parkinson's Research
  • Roswell Park Cancer Institute
  • State University of New York
  • New York State Stem Cell Science
  • National Natural Science Foundation of China (30928006)
  • National Institutes of Health (5rc2ns070276-02, NS070276)
  • U.S. Public Health Service (C024406)
  • National Institute of Mental Health (R25MH077823)
  • National Institute on Drug Abuse (R01DA026947)
  • National Institute of Neurological Disorders and Stroke (RC2-NS070276, NS061856, R01NS061856, NS071122, NS070276, R01NS071122)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
Parkin, Parkinson's disease, dopaminergic neurons, midbrain, dopamine uptake, dopamine release, monoamine oxidase, oxidative stress, induced pluripotent stem cells, parkin mutations, ubiquitin ligase, disease-modifying therapy
MeSH terms
Animals, Binding Sites, Brain, Dopamine, Fibroblasts, Gene Expression Regulation, Humans, Mitochondria, Models, Biological, Monoamine Oxidase, Mutation, Neurons, Oxygen, Parkinson Disease, Phenotype, Skin, Time Factors, Oxidative Stress, Ubiquitin-Protein Ligases, Mice, Induced Pluripotent Stem Cells, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.